Literature DB >> 20025574

Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma.

G Song1, G G Chen, J-P Yun, P B S Lai.   

Abstract

Appropriate subcellular localization of proteins is crucial for regulating their functions. Both p53 and the BH3-only Bid play roles in the development and the treatment of hepatocellular carcinoma (HCC). They both participate in the cross talk of cell cycle arrest and apoptosis in response to DNA damage. However, some important issues related to their pathways are not yet resolved. Bid genomic loci contain p53-binding DNA response elements and Bid can mediate p53-dependent transactivation. Here, we showed that etoposide-induced DNA damage could significantly induce p53 and Bid nuclear export. When cells were stimulated by etoposide, p53 could, through the association with Bid, cause translocation of Bid from the nucleus to the cytoplasm and on to its ultimate location in the mitochondria. p53 was physically associated with Bid, and both p53 and Bid cooperatively promoted cell death induced by etoposide. Knockdown of Bid expression notably attenuated cell death induced by etoposide and also released p53 from the mitochondria. These findings reveal a novel mechanism by which p53 is associated with Bid in the nucleus to facilitate exportation of Bid to the mitochondria and induce apoptosis in response to etoposide-induced DNA damage in HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025574     DOI: 10.2174/156800909789760302

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  6 in total

Review 1.  Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Zbigniew Wyżewski; Matylda Barbara Mielcarska; Karolina Paulina Gregorczyk-Zboroch; Anna Myszka
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

Authors:  Vikash Reebye; Pål Sætrom; Paul J Mintz; Kai-Wen Huang; Piotr Swiderski; Ling Peng; Cheng Liu; Xiaoxuan Liu; Steen Lindkaer-Jensen; Dimitris Zacharoulis; Nikolaos Kostomitsopoulos; Noriyuki Kasahara; Joanna P Nicholls; Long R Jiao; Madhava Pai; Duncan R Spalding; Malkhaz Mizandari; Tinatin Chikovani; Mohamed M Emara; Abdelali Haoudi; Donald A Tomalia; John J Rossi; Nagy A Habib
Journal:  Hepatology       Date:  2013-12-09       Impact factor: 17.425

3.  Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.

Authors:  Young Bong Choi; Gordon Sandford; John Nicholas
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

Review 4.  Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.

Authors:  Saad Shaaban; Amr Negm; Elsayed E Ibrahim; Ahmed A Elrazak
Journal:  Oncol Rev       Date:  2014-05-28

5.  Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway.

Authors:  Chun Hu; Gang Song; Bing Zhang; Zhongchen Liu; Rong Chen; Hong Zhang; Tianhui Hu
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

6.  Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells.

Authors:  Yuanyue Li; Congjie Dai; Juan Li; Weiwei Wang; Gang Song
Journal:  Onco Targets Ther       Date:  2012-10-17       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.